More about

Atopic Dermatitis

News
April 19, 2023
2 min read
Save

Validated IGA for atopic dermatitis strongly correlates with patient-reported outcomes

Validated IGA for atopic dermatitis strongly correlates with patient-reported outcomes

The validated IGA for atopic dermatitis tool proved to be a reliable and accurate means to assess disease severity and quality of life among adults, adolescents and pediatric patients, according to a study.

News
April 14, 2023
1 min read
Save

Top in allergy/asthma: Tree nut immunotherapy; dupilumab for atopic dermatitis

Top in allergy/asthma: Tree nut immunotherapy; dupilumab for atopic dermatitis

The safety profile of oral immunotherapy for tree nut allergies among preschoolers was comparable to that of peanut oral immunotherapy, according to recent study results.

News
April 07, 2023
1 min read
Save

Top in allergy/asthma: Acute asthma exacerbations; atopic dermatitis treatment

Top in allergy/asthma: Acute asthma exacerbations; atopic dermatitis treatment

Age, type of asthma, previous ED admission and family history were all associated with an increased risk for hospital admission among children with acute asthma exacerbations, recent data show.

News
April 03, 2023
3 min read
Save

Dupilumab not linked to short-term cancer development in patients with atopic dermatitis

Dupilumab not linked to short-term cancer development in patients with atopic dermatitis

Patients with atopic dermatitis treated with dupilumab did not experience any significantly increased risk for a primary or recurrent malignancy, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
March 30, 2023
3 min read
Save

Atopic dermatitis treatment reduces food allergy among infants, but inhibits growth

Atopic dermatitis treatment reduces food allergy among infants, but inhibits growth

The use of topical corticosteroids to treat atopic dermatitis in infants also may help prevent hen’s egg allergy, but it may inhibit the baby’s growth as well, according to a study published in The Journal of Allergy & Clinical Immunology.

News
March 27, 2023
1 min read
Save

Dupilumab improves atopic dermatitis symptoms, quality of life in older adults

Dupilumab improves atopic dermatitis symptoms, quality of life in older adults

Dupilumab was associated with improved clinical, safety and quality of life parameters in older patients with moderate to severe atopic dermatitis, according to findings from a post-hoc analysis of four studies.

News
March 24, 2023
2 min read
Save

Lebrikizumab effective against moderate to severe atopic dermatitis, trials find

Lebrikizumab effective against moderate to severe atopic dermatitis, trials find

Two phase 3 trials found that lebrikizumab was effective against moderate-to-severe atopic dermatitis in adolescents and adults, researchers reported in The New England Journal of Medicine.

News
March 23, 2023
2 min read
Save

Lebrikizumab viable treatment alternative to JAK inhibitors in atopic dermatitis

Lebrikizumab viable treatment alternative to JAK inhibitors in atopic dermatitis

NEW ORLEANS — Advancements in atopic dermatitis treatment have allowed prescribers and patients to choose between various options, according to a presenter at the American Academy of Dermatology Annual Meeting.

News
March 23, 2023
1 min read
Save

CBP-201 shows favorable atopic dermatitis results in pivotal trial

CBP-201 shows favorable atopic dermatitis results in pivotal trial

NEW ORLEANS — A greater proportion of patients with atopic dermatitis experienced complete IGA improvement with CBP-201 vs. vehicle, according to a study presented at the American Academy of Dermatology Annual Meeting.

News
March 22, 2023
3 min watch
Save

VIDEO: Gladskin, Level Ex partner for educational dermatology video game

VIDEO: Gladskin, Level Ex partner for educational dermatology video game

NEW ORLEANS — Gladskin and Level Ex have partnered to create a medical video game designed to teach dermatologists how Gladskin’s eczema cream works to restore the skin’s microbiome.

View more